Dacarbazine Concept

Vocabulary Service

MeSH

Overview

subject area of

ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma Journal Articles
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma Journal Articles
Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma Journal Articles
Current approaches to the treatment of advanced-stage Hodgkin's disease. Journal Articles
Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme Journal Articles
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma Journal Articles
Eight Cycles of ABVD Versus Four Cycles of BEACOPP_escalatedPlus Four Cycles of BEACOPP_baselinein Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial Journal Articles
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6 Journal Articles
Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma? Journal Articles
Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma Journal Articles
Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy Journal Articles
Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection Journal Articles
Paraspinal Synovial Sarcoma as an Unusual Postradiation Complication in Pediatric Abdominal Neuroblastoma Journal Articles
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma Journal Articles
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients pre‐screened for low O⁶‐methylguanine DNA methyltransferase expression Journal Articles
Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma Journal Articles
Radiation in early-stage Hodgkin lymphoma. Journal Articles
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group Journal Articles
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma Journal Articles
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group. Journal Articles
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy Journal Articles
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial Journal Articles
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma Journal Articles
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG) Journal Articles
Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study Journal Articles
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group. Journal Articles
VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma Journal Articles
What drives requests for MAiD? Journal Articles